第一期是指在武汉的那个临床实验。今天公布结果了。

https://finance.yahoo.com/m/f199c3c0-6bbe-363a-85a5-f63fe44871c7/gilead-antiviral-drug.html

A potential antiviral drug for the coronavirus has flopped in its first randomised clinical trial, disappointing scientists and investors who had high hopes for remdesivir, according to draft documents published accidentally by the World Health Organization and seen by the Financial Times. The Chinese trial showed remdesivir — developed by California-based Gilead Sciences — did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream. Gilead warned that the post included “inappropriate characterisations of the study”.